36361 |
Oncology |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management... |
ANN ONCOL 2020 10.1016/j.annonc.2019.12.001 |
임호영 |
2020 |
36360 |
Oncology |
Impact of Prior Ramucirumab Use on Treatment Outcomes of Checkpoint In... |
TARGET ONCOL 2020 10.1007/s11523-020-00713-1 |
임호영 |
2020 |
36359 |
Oncology |
Gemcitabine plus carboplatin versus gemcitabine plus oxaliplatin in ci... |
EUR J CANCER 2020 10.1016/j.ejca.2019.08.034 |
임호영 |
2020 |
36358 |
Oncology |
First-in-human phase I trial of anti-hepatocyte growth factor antibody... |
THER ADV MED ONCOL 2020 10.1177/1758835920926796 |
임호영 |
2020 |
36357 |
Oncology |
Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gas... |
J ONCOL 2020 10.1155/2020/4659062 |
임호영 |
2020 |
36356 |
Genetics & Heredity |
Comprehensive pharmacogenomic characterization of gastric cancer |
Genome Med 2020 10.1186/s13073-020-0717-8 |
임호영 |
2020 |
36355 |
Oncology |
Claudin 18.2 expression in various tumor types and its role as a poten... |
Transl Cancer Res 2020 10.21037/tcr-19-1876 |
임호영 |
2020 |
36354 |
Oncology |
Carcinoembryonic Antigen Improves the Performance of Magnetic Resonanc... |
CANCER RES TREAT 2020 10.4143/crt.2019.261 |
임호영 |
2020 |
36353 |
Medicine, General & Internal |
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma |
NEW ENGL J MED 2020 10.1056/NEJMoa1915745 |
임호영 |
2020 |
36352 |
Radiology, Nuclear Medicine & Medical Imaging |
Updated 10-year outcomes of percutaneous radiofrequency ablation as fi... |
EUR RADIOL 2020 10.1007/s00330-019-06575-0 |
임현철 |
2020 |